Mangalam Drugs & Organics Limited (NSE:MANGALAM)
India · Delayed Price · Currency is INR 29.87
+0.46 (1.56%)
May 25, 2026, 10:34 AM IST
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 474.69 million as of May 22, 2026. Its market cap has decreased by -61.05% in one year.
Market Cap
474.69M
Enterprise Value
1.59B
Revenue
2.33B
Ranking
n/a
PE Ratio
n/a
Stock Price
29.87
Market Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 474.69M, an increase of 121.44%. That is a compound annual growth rate of 3.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 474.69M | 8.70% |
| Dec 31, 2025 | 436.70M | -76.09% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 7.78B |
| Valiant Laboratories | 4.18B |
| Bafna Pharmaceuticals | 3.19B |
| Nectar Lifesciences | 2.34B |
| Brooks Laboratories | 1.58B |
| Alpa Laboratories | 1.46B |
| Balaxi Pharmaceuticals | 1.38B |
| Par Drugs and Chemicals | 1.06B |